The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Preimplantation Genetic Diagnosis-Global Market Insights and Sales Trends 2025
Synopsis
Preimplantation Genetic Diagnosis (PGD) is a technique used for detecting genetic defects in embryos developed through in vitro fertilization (IVF) before pregnancy. PGD involves performing tests on embryos to determine genetic abnormality. PGD is an alternative to current post conception diagnostic procedures.
The global Preimplantation Genetic Diagnosis market size is expected to reach US$ 914 million by 2029, growing at a CAGR of 8.9% from 2023 to 2029. The market is mainly driven by the significant applications of Preimplantation Genetic Diagnosis in various end use industries. The expanding demands from the Fertility Clinics and Research, are propelling Preimplantation Genetic Diagnosis market. Genetic Diagnosis, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Genetic Screening segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Preimplantation Genetic Diagnosis market, driven by demand from China, the second largest economy with some signs of stabilising, the Preimplantation Genetic Diagnosis market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Preimplantation Genetic Diagnosis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Preimplantation Genetic Diagnosis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Preimplantation Genetic Diagnosis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Preimplantation Genetic Diagnosis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Preimplantation Genetic Diagnosis covered in this report include Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Perkinelmer, Inc., Coopersurgical, ABBott Laboratories, Natera, Inc., Rubicon Genomics and Oxford Gene Technology, etc.
The global Preimplantation Genetic Diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina, Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Perkinelmer, Inc.
Coopersurgical
ABBott Laboratories
Natera, Inc.
Rubicon Genomics
Oxford Gene Technology
Yikon Genomics
Scigene
Global Preimplantation Genetic Diagnosis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Preimplantation Genetic Diagnosis market, Segment by Type:
Genetic Diagnosis
Genetic Screening
Global Preimplantation Genetic Diagnosis market, by Application
Fertility Clinics
Research
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Preimplantation Genetic Diagnosis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Preimplantation Genetic Diagnosis (PGD) is a technique used for detecting genetic defects in embryos developed through in vitro fertilization (IVF) before pregnancy. PGD involves performing tests on embryos to determine genetic abnormality. PGD is an alternative to current post conception diagnostic procedures.
The global Preimplantation Genetic Diagnosis market size is expected to reach US$ 914 million by 2029, growing at a CAGR of 8.9% from 2023 to 2029. The market is mainly driven by the significant applications of Preimplantation Genetic Diagnosis in various end use industries. The expanding demands from the Fertility Clinics and Research, are propelling Preimplantation Genetic Diagnosis market. Genetic Diagnosis, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Genetic Screening segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Preimplantation Genetic Diagnosis market, driven by demand from China, the second largest economy with some signs of stabilising, the Preimplantation Genetic Diagnosis market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Preimplantation Genetic Diagnosis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Preimplantation Genetic Diagnosis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Preimplantation Genetic Diagnosis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Preimplantation Genetic Diagnosis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Preimplantation Genetic Diagnosis covered in this report include Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Perkinelmer, Inc., Coopersurgical, ABBott Laboratories, Natera, Inc., Rubicon Genomics and Oxford Gene Technology, etc.
The global Preimplantation Genetic Diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina, Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Perkinelmer, Inc.
Coopersurgical
ABBott Laboratories
Natera, Inc.
Rubicon Genomics
Oxford Gene Technology
Yikon Genomics
Scigene
Global Preimplantation Genetic Diagnosis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Preimplantation Genetic Diagnosis market, Segment by Type:
Genetic Diagnosis
Genetic Screening
Global Preimplantation Genetic Diagnosis market, by Application
Fertility Clinics
Research
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Preimplantation Genetic Diagnosis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Preimplantation Genetic Diagnosis
1.1 Preimplantation Genetic Diagnosis Market Overview
1.1.1 Preimplantation Genetic Diagnosis Product Scope
1.1.2 Preimplantation Genetic Diagnosis Market Status and Outlook
1.2 Global Preimplantation Genetic Diagnosis Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Preimplantation Genetic Diagnosis Market Size by Region (2018-2029)
1.4 Global Preimplantation Genetic Diagnosis Historic Market Size by Region (2018-2023)
1.5 Global Preimplantation Genetic Diagnosis Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Preimplantation Genetic Diagnosis Market Size (2018-2029)
1.6.1 North America Preimplantation Genetic Diagnosis Market Size (2018-2029)
1.6.2 Europe Preimplantation Genetic Diagnosis Market Size (2018-2029)
1.6.3 Asia-Pacific Preimplantation Genetic Diagnosis Market Size (2018-2029)
1.6.4 Latin America Preimplantation Genetic Diagnosis Market Size (2018-2029)
1.6.5 Middle East & Africa Preimplantation Genetic Diagnosis Market Size (2018-2029)
2 Preimplantation Genetic Diagnosis Market by Type
2.1 Introduction
2.1.1 Genetic Diagnosis
2.1.2 Genetic Screening
2.2 Global Preimplantation Genetic Diagnosis Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Preimplantation Genetic Diagnosis Historic Market Size by Type (2018-2023)
2.2.2 Global Preimplantation Genetic Diagnosis Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Preimplantation Genetic Diagnosis Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Preimplantation Genetic Diagnosis Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Preimplantation Genetic Diagnosis Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Preimplantation Genetic Diagnosis Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Preimplantation Genetic Diagnosis Revenue Breakdown by Type (2018-2029)
3 Preimplantation Genetic Diagnosis Market Overview by Application
3.1 Introduction
3.1.1 Fertility Clinics
3.1.2 Research
3.2 Global Preimplantation Genetic Diagnosis Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Preimplantation Genetic Diagnosis Historic Market Size by Application (2018-2023)
3.2.2 Global Preimplantation Genetic Diagnosis Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Preimplantation Genetic Diagnosis Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Preimplantation Genetic Diagnosis Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Preimplantation Genetic Diagnosis Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Preimplantation Genetic Diagnosis Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Preimplantation Genetic Diagnosis Revenue Breakdown by Application (2018-2029)
4 Preimplantation Genetic Diagnosis Competition Analysis by Players
4.1 Global Preimplantation Genetic Diagnosis Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Preimplantation Genetic Diagnosis as of 2022)
4.3 Date of Key Players Enter into Preimplantation Genetic Diagnosis Market
4.4 Global Top Players Preimplantation Genetic Diagnosis Headquarters and Area Served
4.5 Key Players Preimplantation Genetic Diagnosis Product Solution and Service
4.6 Competitive Status
4.6.1 Preimplantation Genetic Diagnosis Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Illumina, Inc.
5.1.1 Illumina, Inc. Profile
5.1.2 Illumina, Inc. Main Business
5.1.3 Illumina, Inc. Preimplantation Genetic Diagnosis Products, Services and Solutions
5.1.4 Illumina, Inc. Preimplantation Genetic Diagnosis Revenue (US$ Million) & (2018-2023)
5.1.5 Illumina, Inc. Recent Developments
5.2 Thermo Fisher Scientific Inc.
5.2.1 Thermo Fisher Scientific Inc. Profile
5.2.2 Thermo Fisher Scientific Inc. Main Business
5.2.3 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnosis Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnosis Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Inc. Recent Developments
5.3 Agilent Technologies, Inc.
5.3.1 Agilent Technologies, Inc. Profile
5.3.2 Agilent Technologies, Inc. Main Business
5.3.3 Agilent Technologies, Inc. Preimplantation Genetic Diagnosis Products, Services and Solutions
5.3.4 Agilent Technologies, Inc. Preimplantation Genetic Diagnosis Revenue (US$ Million) & (2018-2023)
5.3.5 Perkinelmer, Inc. Recent Developments
5.4 Perkinelmer, Inc.
5.4.1 Perkinelmer, Inc. Profile
5.4.2 Perkinelmer, Inc. Main Business
5.4.3 Perkinelmer, Inc. Preimplantation Genetic Diagnosis Products, Services and Solutions
5.4.4 Perkinelmer, Inc. Preimplantation Genetic Diagnosis Revenue (US$ Million) & (2018-2023)
5.4.5 Perkinelmer, Inc. Recent Developments
5.5 Coopersurgical
5.5.1 Coopersurgical Profile
5.5.2 Coopersurgical Main Business
5.5.3 Coopersurgical Preimplantation Genetic Diagnosis Products, Services and Solutions
5.5.4 Coopersurgical Preimplantation Genetic Diagnosis Revenue (US$ Million) & (2018-2023)
5.5.5 Coopersurgical Recent Developments
5.6 ABBott Laboratories
5.6.1 ABBott Laboratories Profile
5.6.2 ABBott Laboratories Main Business
5.6.3 ABBott Laboratories Preimplantation Genetic Diagnosis Products, Services and Solutions
5.6.4 ABBott Laboratories Preimplantation Genetic Diagnosis Revenue (US$ Million) & (2018-2023)
5.6.5 ABBott Laboratories Recent Developments
5.7 Natera, Inc.
5.7.1 Natera, Inc. Profile
5.7.2 Natera, Inc. Main Business
5.7.3 Natera, Inc. Preimplantation Genetic Diagnosis Products, Services and Solutions
5.7.4 Natera, Inc. Preimplantation Genetic Diagnosis Revenue (US$ Million) & (2018-2023)
5.7.5 Natera, Inc. Recent Developments
5.8 Rubicon Genomics
5.8.1 Rubicon Genomics Profile
5.8.2 Rubicon Genomics Main Business
5.8.3 Rubicon Genomics Preimplantation Genetic Diagnosis Products, Services and Solutions
5.8.4 Rubicon Genomics Preimplantation Genetic Diagnosis Revenue (US$ Million) & (2018-2023)
5.8.5 Rubicon Genomics Recent Developments
5.9 Oxford Gene Technology
5.9.1 Oxford Gene Technology Profile
5.9.2 Oxford Gene Technology Main Business
5.9.3 Oxford Gene Technology Preimplantation Genetic Diagnosis Products, Services and Solutions
5.9.4 Oxford Gene Technology Preimplantation Genetic Diagnosis Revenue (US$ Million) & (2018-2023)
5.9.5 Oxford Gene Technology Recent Developments
5.10 Yikon Genomics
5.10.1 Yikon Genomics Profile
5.10.2 Yikon Genomics Main Business
5.10.3 Yikon Genomics Preimplantation Genetic Diagnosis Products, Services and Solutions
5.10.4 Yikon Genomics Preimplantation Genetic Diagnosis Revenue (US$ Million) & (2018-2023)
5.10.5 Yikon Genomics Recent Developments
5.11 Scigene
5.11.1 Scigene Profile
5.11.2 Scigene Main Business
5.11.3 Scigene Preimplantation Genetic Diagnosis Products, Services and Solutions
5.11.4 Scigene Preimplantation Genetic Diagnosis Revenue (US$ Million) & (2018-2023)
5.11.5 Scigene Recent Developments
6 North America
6.1 North America Preimplantation Genetic Diagnosis Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Preimplantation Genetic Diagnosis Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Preimplantation Genetic Diagnosis Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Preimplantation Genetic Diagnosis Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Preimplantation Genetic Diagnosis Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Preimplantation Genetic Diagnosis Market Dynamics
11.1 Preimplantation Genetic Diagnosis Industry Trends
11.2 Preimplantation Genetic Diagnosis Market Drivers
11.3 Preimplantation Genetic Diagnosis Market Challenges
11.4 Preimplantation Genetic Diagnosis Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
